Bio-Techne released the new USP mAb 004 (IgG4) standard as an additional well-characterized mAb reference material for analytical method development, qualification, and routine performance monitoring.
Published
Signal category
Products & Services
Quote
“Available now: The new USP mAb 004 (IgG4) standard, an additional well-characterized mAb reference material for analytical method development, qualification, & routine performance monitoring.”
— Andy Clarke|Bio-Techne team
Company
- Industry
- Biotechnology Research
- Location
- Minneapolis, US
- Company size
- 2,996 employees
Bio-Techne is a global life sciences company that empowers scientific discovery and advances human health. Through its industry-leading branded product portfolios, including R&D Systems™ by Bio-Techne, Bio-Techne Spatial™, and Bio-Techne Diagnostics™, the company delivers high-quality solutions and expert support that enable scientists and clinicians to make breakthrough discoveries, develop and manufacture novel therapeutics and deliver precision diagnostics across cancer research, neuroscience, diabetes, rare diseases, and beyond. Bio-Techne®, Bio-Techne Diagnostics™, Bio-Techne Spatial ™, R&D Systems™ are trademarks or registered trademarks of Bio-Techne Corporation and affiliated entities. All other trademarks, service marks, and trade names are the property of their respective owners.